{"cord_uid": "sb3ccvsk", "sourcedb": "PMC", "sourceid": "PMC5030268", "divid": "5", "text": "Mice , infection , and Foxp3 + Treg Depletion C57BL / 6 WT mice were purchased from the National Cancer Institute ( Frederick , MD , USA ) . C57BL / 6 DEREG mice , which express the enhanced green fluorescent protein ( eGFP ) and diphtheria toxin receptor ( DTR ) under the control of the Foxp3 promoter , were kindly provided by Dr . T . Sparwasser ( Twincore , Hannover , Germany ) ( 22 ) . C57BL / 6 homozygous IL - 27R\u03b1 ( WSX - 1 ) deficient ( IL - 27R \u2212 / \u2212 ) mice were provided by Dr . C . Saris ( Amgen , Thousand Oaks , CA , USA ) . Mice were bred and maintained at the Biological Resources Unit of the Cleveland Clinic Lerner Research Institute under sterile conditions . All procedures were performed in compliance with protocols approved by the Cleveland Clinic Institutional Animal Care and Use Committee . Mice of both sexes at 6 - 7 weeks of age were infected in the left hemisphere with 1 , 000 plaque forming unit ( PFU ) of the sublethal gliatropic JHMV monoclonal antibody ( mAb ) derived variant designated 2 . 2v - 1 ( 25 ) in 30 - \u03bcl endotoxin - free Dulbecco ' s phosphate - buffered saline ( PBS ) . Mice were assessed daily for clinical disease severity according to the following scale : 0 , healthy ; 1 , hunched back and ruffled fur ; 2 , partial hind limb paralysis or inability to maintain the upright position ; 3 , complete hind limb paralysis ; 4 , moribund or dead . For Foxp3 + Treg depletion , DEREG mice and control littermates ( Foxp3 eGFP DTR \u2212 mice ) received daily intraperitoneal ( i . p . ) injections of 1 - \u03bcg DT ( EMD Biosciences , San Diego , CA , USA ) between days 21 and 28 post infection ( p . i . ) .", "project": "cdlai_CORD-19", "denotations": [{"id": 1, "span": {"begin": 182, "end": 217}, "obj": "Gene"}]}